Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.

Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J.

FASEB J. 2005 Apr;19(6):533-42.

PMID:
15791003
[PubMed - indexed for MEDLINE]
Free Article
2.

[Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease].

Qiao S, Luo JH, Jin JH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Mar;41(2):210-4. Review. Chinese.

PMID:
22499522
[PubMed - indexed for MEDLINE]
3.

Immunological features of alpha-synuclein in Parkinson's disease.

Roodveldt C, Christodoulou J, Dobson CM.

J Cell Mol Med. 2008 Oct;12(5B):1820-9. doi: 10.1111/j.1582-4934.2008.00450.x. Epub 2008 Jul 30. Review. Erratum in: J Cell Mol Med. 2008 Dec;12(6B):2875.

PMID:
18671754
[PubMed - indexed for MEDLINE]
4.

Glial reactions in Parkinson's disease.

McGeer PL, McGeer EG.

Mov Disord. 2008 Mar 15;23(4):474-83. Review.

PMID:
18044695
[PubMed - indexed for MEDLINE]
5.
6.

Inflammation as a causative factor in the aetiology of Parkinson's disease.

Whitton PS.

Br J Pharmacol. 2007 Apr;150(8):963-76. Epub 2007 Mar 5. Review.

PMID:
17339843
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The role of glial cells in Parkinson's disease.

Vila M, Jackson-Lewis V, Guégan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S.

Curr Opin Neurol. 2001 Aug;14(4):483-9. Review.

PMID:
11470965
[PubMed - indexed for MEDLINE]
8.

Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease.

Panaro MA, Cianciulli A.

Curr Pharm Des. 2012;18(2):200-8. Review.

PMID:
22229581
[PubMed - indexed for MEDLINE]
9.

[Pathological mechanisms of Parkinson's disease].

Matsui H, Takahashi R.

Brain Nerve. 2009 Apr;61(4):441-6. Review. Japanese.

PMID:
19378814
[PubMed - indexed for MEDLINE]
10.

α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.

Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P.

Brain Res. 2012 Jan 13;1432:95-113. doi: 10.1016/j.brainres.2011.11.031. Epub 2011 Nov 19. Review.

PMID:
22153624
[PubMed - indexed for MEDLINE]
11.

Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Kim YS, Joh TH.

Exp Mol Med. 2006 Aug 31;38(4):333-47. Review.

PMID:
16953112
[PubMed - indexed for MEDLINE]
Free Article
12.

Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Qian L, Flood PM, Hong JS.

J Neural Transm. 2010 Aug;117(8):971-9. doi: 10.1007/s00702-010-0428-1. Epub 2010 Jun 23. Review.

PMID:
20571837
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

Sidhu A, Wersinger C, Vernier P.

FASEB J. 2004 Apr;18(6):637-47. Review.

PMID:
15054086
[PubMed - indexed for MEDLINE]
Free Article
14.

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Tansey MG, Goldberg MS.

Neurobiol Dis. 2010 Mar;37(3):510-8. doi: 10.1016/j.nbd.2009.11.004. Epub 2009 Nov 10. Review.

PMID:
19913097
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Neurodegeneration and inflammation in Parkinson's disease.

Phani S, Loike JD, Przedborski S.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S207-9. doi: 10.1016/S1353-8020(11)70064-5. Review.

PMID:
22166436
[PubMed - indexed for MEDLINE]
16.

NADPH oxidase as a therapeutic target in Alzheimer's disease.

Block ML.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S8. doi: 10.1186/1471-2202-9-S2-S8. Review.

PMID:
19090996
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Can Parkinson's disease pathology be propagated from one neuron to another?

Dunning CJ, Reyes JF, Steiner JA, Brundin P.

Prog Neurobiol. 2012 May;97(2):205-19. doi: 10.1016/j.pneurobio.2011.11.003. Epub 2011 Nov 18. Review.

PMID:
22115849
[PubMed - indexed for MEDLINE]
18.

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M.

ASN Neuro. 2013 Apr 30;5(2):113-39. doi: 10.1042/AN20120066. Review.

PMID:
23506036
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease.

Béraud D, Maguire-Zeiss KA.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S17-20. doi: 10.1016/S1353-8020(11)70008-6. Review.

PMID:
22166424
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

alpha-Synuclein: a therapeutic target for Parkinson's disease?

Maguire-Zeiss KA.

Pharmacol Res. 2008 Nov-Dec;58(5-6):271-80. doi: 10.1016/j.phrs.2008.09.006. Epub 2008 Sep 16. Review.

PMID:
18840530
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk